We aimed to evaluate the mRNA expression of VISTA, Galectin-9, and TIM-3 on CD8+ T-cells and leukemic cells in B-cell acute lymphoblastic leukemia (B-ALL). The gene discussed is CD8A; the disease is B-cell acute lymphoblastic leukemia.